Addex Therapeutics Ltd (FRA:APE)
Germany
· Delayed Price · Currency is EUR 0.0605
+0.0235 (63.51%)
At close: Jul 3, 2025
Addex Therapeutics Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 8.67 | 7.06 | -10.56 | -20.8 | -15.35 | -12.86 | Upgrade
|
Depreciation & Amortization | 0.19 | 0.19 | 0.01 | 0.01 | 0.35 | 0.38 | Upgrade
|
Loss (Gain) on Equity Investments | 3.02 | 2.18 | - | - | - | - | Upgrade
|
Stock-Based Compensation | 0.14 | 0.18 | 0.28 | 0.68 | 1.34 | 1.46 | Upgrade
|
Other Operating Activities | -0.05 | -0.18 | 0.29 | 0.2 | -0.28 | 0.66 | Upgrade
|
Change in Accounts Receivable | 0.19 | 0.13 | 0.45 | -0.27 | -0.26 | 0.05 | Upgrade
|
Change in Accounts Payable | -1.92 | -1.15 | -0.61 | -0.43 | 0.88 | -1.59 | Upgrade
|
Change in Unearned Revenue | 0.29 | -0.04 | 0.32 | - | -0.82 | -0.46 | Upgrade
|
Change in Other Net Operating Assets | -0.36 | -0.18 | 0.06 | 0.86 | -0.57 | 0.17 | Upgrade
|
Operating Cash Flow | -3.78 | -5.37 | -7.99 | -16.44 | -14.71 | -12.18 | Upgrade
|
Capital Expenditures | -0 | -0 | -0.01 | -0 | -0.03 | -0.06 | Upgrade
|
Investment in Securities | - | - | - | 0 | 0 | - | Upgrade
|
Other Investing Activities | 4.65 | 4.65 | - | - | - | - | Upgrade
|
Investing Cash Flow | 4.65 | 4.65 | -0.01 | 0 | -0.03 | -0.06 | Upgrade
|
Long-Term Debt Repaid | - | -0.07 | -0.28 | -0.29 | -0.31 | -0.37 | Upgrade
|
Net Debt Issued (Repaid) | -0.01 | -0.07 | -0.28 | -0.29 | -0.31 | -0.37 | Upgrade
|
Issuance of Common Stock | 0 | 0.24 | 2.35 | 1.68 | 13.96 | 0.72 | Upgrade
|
Repurchase of Common Stock | -0.02 | -0.03 | -0.05 | -0.31 | -0.39 | - | Upgrade
|
Other Financing Activities | 0.06 | -0.04 | 3.24 | 2.02 | 3.14 | -0.31 | Upgrade
|
Financing Cash Flow | 0.04 | 0.1 | 5.26 | 3.1 | 16.4 | 0.05 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.01 | 0.1 | -0.36 | -0.2 | 0.12 | -0.65 | Upgrade
|
Net Cash Flow | 1.2 | -0.52 | -3.09 | -13.53 | 1.79 | -12.84 | Upgrade
|
Free Cash Flow | -3.78 | -5.37 | -8 | -16.44 | -14.74 | -12.24 | Upgrade
|
Free Cash Flow Margin | -1535.08% | -1310.80% | -494.64% | -1137.59% | -467.34% | -315.52% | Upgrade
|
Free Cash Flow Per Share | -0.04 | -0.06 | -0.11 | -0.36 | -0.43 | -0.46 | Upgrade
|
Cash Interest Paid | 0 | 0.01 | 0.02 | 0.05 | 0.06 | 0.07 | Upgrade
|
Levered Free Cash Flow | -3.9 | -3.01 | -0.99 | -6.19 | -8.2 | -7.85 | Upgrade
|
Unlevered Free Cash Flow | -3.9 | -3.01 | -0.99 | -6.17 | -8.16 | -7.81 | Upgrade
|
Change in Net Working Capital | 2.3 | 1.66 | -0.13 | 0.27 | 0.13 | 1.94 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.